Navigation Links
Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season
Date:5/6/2008

"Clear to Drive" Campaign Urges Allergy Sufferers to Check Medicine Labels

for Drowsiness Warnings Before Getting Behind the Wheel

KENILWORTH, N.J., May 6 /PRNewswire-FirstCall/ -- Summer is fast approaching, bringing sunshine, vacation days, and trips to the beach. But the warmer weather also marks a peak in seasonal allergies and the beginning of a busy driving season. According to a recent survey, seven out of ten Americans believe they will spend some time driving this Memorial Day weekend.

This year, the makers of the non-drowsy allergy medication CLARITIN(R) are partnering with Lori Loughlin, a popular actress, mom and allergy sufferer, best known for her role as Rebecca Donaldson on the hit sitcom Full House. The campaign aims to raise awareness about the importance of reading medicine labels, including allergy medicines, for warnings about drowsiness before they get behind the wheel.

Like many working moms, Lori spends hours each day shuttling her children to school, activities, and play-dates in the high-traffic Los Angeles area. It's especially important to Lori that she's focused behind the wheel with her most precious cargo in the back seat.

"As an allergy sufferer, I was surprised to learn that some over-the- counter medicines may cause drowsiness. In fact, the allergy medicine I used to take made me drowsy. I thought there was something wrong with me because I was so sleepy -- which was pretty dangerous considering all the driving I do with my kids," said Lori. "Then I discovered CLARITIN, which relieves my worst allergy symptoms for 24 hours without making me drowsy. When you spend as much time driving as I do, you need to be focused."

Lori is not alone -- in fact many drivers don't realize that some common over-the-counter medicines could cause drowsiness. According to a recent survey, four in 10 Americans (38%) report that there have been times when they were driving and realized that the medicine they had taken was making them drowsy.

"We're thrilled that Lori, a well-known actress and mom, recognizes the importance of reading medicine labels for warnings about drowsiness before she gets behind the wheel," said TJ Higgins, Group Vice President, Marketing, Schering-Plough Consumer Healthcare. "Lori is participating in the "Clear to Drive" campaign to help share her story with millions of Americans who might not know that their medicines may cause drowsiness."

For tips on safe driving and to learn more about treating allergies, visit http://www.cleartodrive.com.

About Lori Loughlin

Lori Loughlin is a popular TV and movie actress best known for her role as Rebecca Donaldson on the hit sitcom Full House. Her latest film, "Old Dogs," which also stars John Travolta, Robin Williams, and Seth Rogen, is scheduled to be released next year. Lori resides in Los Angeles with her husband, Mossimo Giannulli, creator of the popular "Mossimo" clothing line, and their three children.

About CLARITIN

All CLARITIN brand products are available without a prescription, including: CLARITIN(R) Tablets, a once-daily full prescription strength, non- drowsy formulation; CLARITIN(R) RediTabs(R) Tablets, a novel once-daily formulation in a quickly dissolving tablet for ages 6 and older; CLARITIN-D(R) 24-hour and 12-hour Extended Release Tablets, with the decongestant pseudoephedrine now located behind the counter; CHILDREN'S CLARITIN(R) Syrup, a liquid formulation for children ages 2 and older in grape and fruit flavors; CHILDREN'S CLARITIN(R) Grape Chewables, a chewable tablet for children ages 2 and older; and CLARITIN Hives Relief(TM) tablets.

CLARITIN is the No. 1 physician-recommended and pediatrician-recommended over-the-counter antihistamine brand for allergic rhinitis. The CLARITIN(R) Rx-to-OTC switch in 2002 was the largest switch ever-and the first and only for a non-sedating antihistamine. For more information on allergies and treatment, visit http://www.CLARITIN.com.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference
2. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
3. New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor
4. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
5. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
6. Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.
7. Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance
8. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
9. Stemline Therapeutics Raises $12.5 Million
10. Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
11. Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
Breaking Biology Technology:
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):